Celexion, founded in 2009, was a bioengineering company developing platform technologies and products for partners in the pharmaceutical, industrial, agricultural and life science research sectors. The company’s Secant Platform assists in the development of biologics. The company’s assets – including its Secant® yeast display platform – were acquired by Agenus in 2015.